Vanessa W. Petit

Vanessa W. Petit

Auto-generated profile, based on publicly available information

Vanessa W. Petit

CEA/DRF/iRCM/LRTS, 92265 Fontenay-aux-Roses cedex, France

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2012 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
ALAdina N. Lazar
Adina N. Lazar
CBClaudia Bich
Claudia Bich
MPMaï Panchal
Maï Panchal
NDNicolas Desbenoit
Nicolas Desbenoit
VPVanessa W. Petit
Vanessa W. Petit
CDCharles Duyckaerts
Charles Duyckaerts

23 November 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
FFFederica FERRI
Federica FERRI
APAude Parcelier
Aude Parcelier
VPVanessa Petit
Vanessa Petit
AGAnne-Sophie Gallouet
Anne-Sophie Gallouet
DLDaniel Lewandowski
Daniel Lewandowski
PRPaul-Henri Romeo
Paul-Henri Romeo
Despite its importance during viral or bacterial infections, transcriptional regulation of the interferon-β gene (Ifnb1) in activated macrophages is only partially understood. Here we report that TRIM33 deficiency results in high, sustained expression of Ifnb1 at late stages of toll-like receptor-mediated activation in macrophages but not in fibroblasts. In macrophages, TRIM33 is recruited by PU.1 to a conserved region, the Ifnb1 Control Element (ICE), located 15 kb upstream of the Ifnb1 transcription start site. ICE constitutively interacts with Ifnb1 through a TRIM33-independent chromatin loop. At late phases of lipopolysaccharide activation of macrophages, TRIM33 is bound to ICE, regulates Ifnb1 enhanceosome loading, controls Ifnb1 chromatin structure and represses Ifnb1 gene transcription by preventing recruitment of CBP/p300. These results characterize a previously unknown mechanism of macrophage-specific regulation of Ifnb1 transcription whereby TRIM33 is critical for Ifnb1 gene transcription shutdown.

1 March 2016 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
VPVanessa W. Petit
Vanessa W. Petit
JRJean-Luc Rolland
Jean-Luc Rolland
ABAlain Blond
Alain Blond
CCChantal Cazevieille
Chantal Cazevieille
CDChakib Djediat
Chakib Djediat
SRSylvie Rebuffat
Sylvie Rebuffat

10 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
AGAnne-Sophie Gallouet
Anne-Sophie Gallouet
FFFederica FERRI
Federica FERRI
VPVanessa Petit
Vanessa Petit
APAude Parcelier
Aude Parcelier
DLDaniel Lewandowski
Daniel Lewandowski
PRPaul-Henri Romeo
Paul-Henri Romeo
Macrophage production and activation are dependent on TRIM33 Macrophage production and activation are dependent on TRIM33

1 April 2009 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
JRJitka Rihakova
Jitka Rihakova
VPVanessa W. Petit
Vanessa W. Petit
KDKaterina Demnerova
Katerina Demnerova
HPHervé PREVOST
Hervé PREVOST
SRSylvie Rebuffat
Sylvie Rebuffat
Djamel DriderDjamel Drider
Djamel Drider
Divercin V41 (DvnV41) is a class IIa bacteriocin with potent antilisterial activity isolated from Carnobacterium divergens V41. Previously, we expressed from a synthetic gene, in Escherichia coli Origami, a recombinant DvnV41 designated DvnRV41, which possesses four additional amino acids (AMDP) in the N-terminal region that result from enzymatic cleavage and retains the initial DvnV41 activity. To unravel the relationship between the structure of DvnRV41 and its particularly elevated activity, we produced by site-directed mutagenesis eight variants in which a single amino acid replacement was specifically introduced into the sequence. The point mutations were designed to change either conserved residues in class IIa bacteriocins or residues specific to DvnV41 located mainly in the C-terminal region. The fusion proteins were purified from the cytosoluble fractions by immobilized affinity chromatography. DvnRV41 and its variants were released from the fusion proteins by enzymatic cleavage, using enterokinase. The purity of DvnRV41 and of the variants was checked by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, high-performance liquid chromatography, and mass spectrometry. The antibacterial activity of DvnRV41 and its variants was assessed using different indicator strains, including Listeria monocytogenes EGDe and Enterococcus faecalis JH2-2. The activity of all of the variants appeared to be less than the activity of DvnRV41. The decrease in activity did not appear to be related to a global conformational change, as determined by circular dichroism. Overall, the variants of DvnRV41 produced in the present study provide interesting insights into structure-activity relationships of class IIa bacteriocins.